Key result
TTE detects cardiac involvement in 1.5% of malignant lymphoma patients, primarily diffuse large B-cell lymphoma.
Why the study?
Diagnosing cardiac involvement in malignant lymphoma without cardiac manifestations is difficult.
Population
453 patients with malignant lymphoma referred to a single hospital
Design
Single-center retrospective observational study
Authors
Loading...
Low detection rate suggests limited utility of routine TTE; hypothesis-generating for targeted screening strategies in lymphoma.
Observational (n=453)
No
Routine transthoracic echocardiography in patients with malignant lymphoma reveals a 1.5% incidence of cardiac involvement, most commonly associated with diffuse large B-cell lymphoma and frequently presenting as pericardial effusion.
Ebina et al. (2023) conducted an observational in Malignant lymphoma (n=453). Transthoracic echocardiography (TTE) was evaluated on Incidence of cardiac involvement detected by TTE. Cardiac involvement was detected by transthoracic echocardiography in 1.5% (6 of 394) of patients with malignant lymphoma, with diffuse large B-cell lymphoma being the most common type involved.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: